Does adjuvant therapy improve overall survival for stage IA/B pancreatic adenocarcinoma?

BACKGROUND: Current guidelines recommend adjuvant chemotherapy for resected pancreatic adeno-carcinoma (PDAC). However, no studies have addressed its survival benefit for stage I patients as they comprise <10% of PDAC. METHODS: Using the NCDB 2006–2012, resected PDAC patients with stage I disease...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:HPB (Oxford)
Main Authors: Ostapoff, Katherine T., Gabriel, Emmanuel, Attwood, Kristopher, Kuvshinoff, Boris W., Nurkin, Steven J., Hochwald, Steven N.
Format: Artigo
Jezik:Inglês
Izdano: 2017
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6324176/
https://ncbi.nlm.nih.gov/pubmed/28433254
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.hpb.2017.03.002
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki